AMBP and prostate carcinoma: Among them, fatty acid binding protein 5 (FABP5), Alpha-1-Microglobulin/Bikunin Precursor (AMBP), Charged Multivesicular Body Protein 4A (CHMP4A), and Charged Multivesicular Body Protein 4C (CHMP4C) were significantly differentially expressed in prostate cancer patients compared to normal samples [19].